COPD Trial, Recruiting NCT06529185 Sponsor: Cairo University Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06529185
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a male aged between 55 and 60 years old with a diagnosis of mild to moderate COPD (Grade I or Grade II)
  • You are in a stable condition, both physically and medically, at the time of joining the study
  • Your body weight is in a healthy range, with a Body Mass Index (BMI) between 18.5 and 24.9
  • You have a history of pain in one leg that occurs during physical activity
  • When walking on a treadmill, your walking is limited by leg pain that comes and goes (a condition sometimes called intermittent claudication, meaning pain that stops you walking but eases with rest)
  • You have reduced blood flow to your legs, confirmed by a specific blood pressure measurement taken at your ankle compared to your arm (confirm with trial site for exact test details)

Who may not be able to join:

  • You have a serious heart or circulation problem that means your heart cannot pump blood effectively
  • You have had a heart attack recently
  • You have heart failure
  • You have an irregular heartbeat (arrhythmia)
  • You have a blood clot in a vein, such as a deep vein thrombosis (DVT)
  • You have raised pressure inside your skull (confirm with trial site)
  • You currently have pneumonia
  • You have kidney failure
  • You have any bone fractures
  • You are unable or unwilling to cooperate with the study requirements
  • You have a cognitive or memory condition that would prevent you from taking part in exercises

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zahra M Serry, Assist.Prof, Cairo University

Phone: +201050770870

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 July 2024
Est. completion
20 December 2024

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Ventilatory function: by spirometry test; Vascular function: by doppler ultrasound

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov